Long-term study of TA-8317 in patients with cancer breakthrough pain
Latest Information Update: 25 May 2016
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 25 May 2016 New trial record